Dana-Farber Cancer Institute presents prostate cancer research at AUA24 (IMAGE)

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute presents prostate cancer research at AUA24

Caption

Dana-Farber Cancer Institute presents research at AUA24 that shows a wider range of patients with metastatic castration-resistant prostate cancer benefit from LuPSMA radioligand therapy. Research presented by Xiao Wei.

Credit

Dana-Farber Cancer Institute

Usage Restrictions

Kindly credit Dana-Farber Cancer Institute

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.